In particular, several in vitro and in vivo studies support the development of compounds targeting P2Y1-R, P2Y2-R and P2Y12-R activities for the prevention and treatment of cardiovascular diseases (Table 1). Here, P2RY12 is linked to cardiovascular disorder.